The effect of hyperbaric oxygen treatment on... (2008 study) Skip to main content
Clinical Study Hepato-gastroenterology 2008

The effect of hyperbaric oxygen treatment on postoperative morbidity of left lobe donor in living donor adult liver transplantation.

Suehiro T, Shimura T, Okamura K, Okada T, Okada K, Hashimoto S, et al., Hepato-gastroenterology, 2008

Tier 2, Indexed

Automatically imported from PubMed based on relevance criteria.

Summary

What Researchers Did

Researchers compared 7 liver donors who received hyperbaric oxygen treatment, starting 3 days after surgery, with 7 donors who did not, after they gave part of their liver for a living donor transplant.

What They Found

In a small study of 14 living liver donors, the 7 who received hyperbaric oxygen treatment had less wound numbness at 28 days after surgery and a higher liver regeneration rate at 4 weeks than the 7 who did not. Wound numbness on day 28 was reported in 86% (6 of 7) of the control group and 29% (2 of 7) of the hyperbaric oxygen group (p less than 0.05). Hospital stay was similar, at 14.4 days in the control group and 14.6 days in the hyperbaric oxygen group (no significant difference). On day 14, the treated group had lower AST and higher PT%. Total bilirubin was lower on days 14 and 28, and albumin was higher on days 7, 10 and 28 (all p less than 0.05). Whole liver, graft and remnant liver volumes did not differ significantly between the groups.

What This Means for Canadian Patients

This abstract looked at people who donate part of their liver to another person. In this small group, those who received hyperbaric oxygen treatment after surgery had less wound numbness and better liver test results at some time points, but the abstract reports no shorter hospital stay. The authors state that the treatment seems very useful in this setting, but the abstract does not give the pressure or number of sessions, so it cannot guide treatment decisions on its own.

Canadian Relevance

No direct Canadian connection identified.

Study Limitations

The study included only 14 donors, 7 per group, and the abstract does not describe how donors were assigned to groups or give the treatment pressure or number of sessions, so the findings are preliminary.

This plain-language summary was generated with AI assistance from the study's abstract; it has not been individually reviewed by a clinician. Always consult the source study and a qualified healthcare professional. See our editorial policy.

Was this summary helpful?

Study Details

Study Type Clinical Study
Category Wound Care
Source Pubmed
PubMed ID 18705320
Year Published 2008
Journal Hepato-gastroenterology
MeSH Terms Adult; Bilirubin; Female; Follow-Up Studies; Hepatectomy; Humans; Hyperbaric Oxygenation; Liver Function Tests; Liver Regeneration; Liver Transplantation; Living Donors; Male; Middle Aged; Postoperative Complications; Serum Albumin

Cite This Study

Share

This study relates to Problem Wounds. Read the full clinical overview, the evidence base, and Canadian treatment access for this condition.

Find a Canadian Clinic Treating Wound Care

Browse verified hyperbaric facilities across Canada.

View Canadian Facilities

Disclaimer: This study summary is provided for informational and educational purposes only. It does not constitute medical advice. The information presented reflects the findings of the original research authors and may not represent the views of Canada Hyperbarics. Always consult a qualified healthcare professional before making treatment decisions.

Last updated: April 1, 2026 | Reviewed by: Canada Hyperbarics Editorial Team | Editorial process | Research sources | Counts & methodology